UK Earnings, Trading Statements Calendar | |
Wednesday, September 10 | |
Accesso Technology Group | Half Year Results |
Alliance Pharma | Half Year Results |
Restore | Half Year Results |
Barratt Developments | Full Year Results |
Advanced Medical Solutions Group | Half Year Results |
Electrical Geodesics | Half Year Results |
Mcbride | Full Year Results |
Superglass Holdings | Trading Statement |
Kingfisher Group | Half Year Results |
Sports Direct International | Interim Management Statement |
Thorntons | Full Year Results |
Optimal Payments | Half Year Results |
London Stock Exchange Group | Trading Statement |
Thursday, September 11 | |
Pacific Horizon | Full Year Results |
Next | Half Year Results |
Ricardo | Full Year Results |
Ashmore Group | Full Year Results |
Darty | Interim Management Statement |
Home Retail Group | Trading Statement |
WM Morrisons Supermarkets | Half Year Results |
Futura Medical | Half Year Results |
Netplay TV | Half Year Results |
Ocado Group | Interim Management Statement |
Dunelm Group | Full Year Results |
Friday, September 12 | |
Anite | Interim Management Statement |
JD Wetherspoon | Full Year Results |
SThree | Interim Management Statement |
Monday, September 15 | |
Monitise | Full Year Results |
City of London Investment Group | Full Year Results |
M.P. Evans Group | Half Year Results |
Plant Health Care | Half Year Results |
Avanti Communications | Full Year Results |
Telit Communications | Half Year Results |
MySale Group | Full Year Results |
Tuesday, September 16 | |
Craneware | Full Year Results |
Euromoney Institutional Investor | Trading Update |
Flowtech Fluidpower | Half Year Results |
Crest Nicholson | Interim Management Statement |
Galliford Try | Full Year Results |
Pan African Resources | Full Year Results |
ASOS | Full Year Results |
IQE | Half Year Results |
Silence Therapeutics | Half Year Results |
Falkland Oil and Gas | Half Year Results |
Thomas Cook Group | Trading Update |
Lidco | Half Year Results |
N Brown Group | Trading Statement |
Porta Communications | Half Year Results |
Copyright 2014 Alliance News Limited. All Rights Reserved. | |
IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia
Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.
Read more